Deferoxamine mesylate

Deferoxamine mesylate

Catalog Number:
FC01365928APE
Mfr. No.:
APE-B6068
Price:
$185
Size:
Quantity:
Add to Cart:
    • Overview
      • Please contact us at for specific academic pricing.

        Background

        Deferoxamine mesylate is a specific iron-chelating agent [1][2][3]Deferoxamine mesylate can be used for treating acute iron intoxication. Deferoxamine complexed with iron to form ferrioxamine and then prevented the iron from entering into further chemical reactions. The formed chelate is readily soluble in water and passes easily through the kidney [1].In Fisher rats transplanted with the 13762NF mammary adenocarcinoma, deferoxamine mesylate reduced rat tumor growth. While deferoxamine mesylate?injections plus a low iron diet caused the greatest inhibitory effect on tumor growth. Deferoxamine mesylate may be a useful chemotherapeutic agent in the treatment of breast cancer [2]. In Sprague-Dawley rats, injected with deferoxamine mesylate (75-90 mg; 300 mg/kg) via the celiac artery before surgery. Deferoxamine mesylate signi?cantly lowered the serum levels of amylase, lipase, and malondialdehyde (MDA) after orthotopic liver autotransplantation. Deferoxamine mesylate also protected pancreatic tissue through up-regulated expression of HIF-1 protein and inhibition of oxidative toxic reactions [3].

        Deferoxamine mesylate (Desferal mesylate). A specific iron-chelating agent for treating acute iron intoxication. Clin Pharmacol Ther. 1969 Jul-Aug;10(4):595-6.
        Wang F, Elliott RL, Head JF. Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma. Anticancer Res. 1999 Jan-Feb;19(1A):445-50.
        Li Y, Zhang PJ, Jin C, et al. Protective effects of deferoxamine mesylate preconditioning on pancreatic tissue in orthotopic liver autotransplantation in rats. Transplant Proc. 2011 Jun;43(5):1450-5.

    • Properties
      • Categories
        iron-chelating agent
        Alternative Name
        (Z)-4-((5-aminopentyl)(hydroxy)amino)-N-(5-((Z)-N,4-dihydroxy-4-((5-(N-hydroxyacetamido)pentyl)imino)butanamido)pentyl)-4-oxobutanimidic acid compound with methanesulfonic acid (1:1)
        CAS Number
        138-14-7
        Molecular Formula
        C26H52N6O11S
        Molecular Weight
        656.79
        Appearance
        A solid
        Purity
        98.00%
        Solubility
        ≥65.7 mg/mL in H2O; insoluble in EtOH; ≥29.8 mg/mL in DMSO
        Storage
        Store at -20°C
        SMILES
        CC(N(O)CCCCC/N=C(O)/CCC(N(O)CCCCC/N=C(O)/CCC(N(O)CCCCCN)=O)=O)=O.CS(O)(=O)=O

        * For Research Use Only

    • Reference
      • 1. Binghua Liu, Weiyan Wang, et al. "Sodium iodate induces ferroptosis in human retinal pigment epithelium ARPE-19 cells." Cell Death Dis. 2021 Mar 3;12(3):230. PMID:33658488
        2. Junhong Zhang, Ni Wang, et al. "Oridonin induces ferroptosis by inhibiting gamma‐glutamyl cycle in TE1 cells." Phytother Res 2020 Aug 31. PMID:32869425
        3. Tianshu Wu, Xue Liang, et al. "Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia." Particle and Fibre Toxicology volume 17, Article number: 30 (2020).11 July 2020.

We Also Recommend

GW 610

$286

W 54011

$365